Table 2 Late toxicity for localized prostate cancer patients with respect to treatment arm (IG-IMRT vs. RP followed by IMRT)
Toxicity | Total | IG-IMRT | RP + IMRT | p-value |
|---|---|---|---|---|
(n= 96) | (n= 49) | (n= 47) | ||
Genitourinary | 0.145 | |||
G0 | 30 (31.3%) | 11 (22.5%) | 19 (40.4%) | |
G1 | 25 (26.0%) | 17 (34.7%) | 8 (17.0%) | |
G2 | 24 (25.0%) | 12 (24.5%) | 12 (25.5%) | |
G3 | 17 (17.7%) | 9 (18.4%) | 8 (17.0%) | |
G4 | - | - | - | |
Gastrointestinal | 0.095 | |||
G0 | 85 (88.5%) | 42 (85.7%) | 43 (91.5%) | |
G1 | 9 (9.4%) | 7 (14.3%) | 2 (4.3%) | |
G2 | - | - | - | |
G3 | 2 (2.1%) | - | 2 (4.3%) | |
G4 | - | - | ||